Newsroom

Sorted by: Latest

-

Terra Firma Energy Welcomes RWE’s Recent Analysis on the Essential Role of Flexible Generation in the UK

LONDON--(BUSINESS WIRE)--Terra Firma Energy Welcomes RWE’s Recent Analysis on the Essential Role of Flexible Generation in the UK...
-

Frank McGrew Joins Greenwich Capital Group to Spearhead Growth and Serve Global Clients from Newly Expanded Nashville Office

NASHVILLE, Tenn.--(BUSINESS WIRE)--Greenwich Capital Group LLC (“GCG”), a leading independent investment bank serving middle-market businesses, private equity firms, and public companies, announced that Frank A. McGrew IV has joined as Managing Director, Co-Head of the Nashville Office, and Co-Head of the Industrials practice. McGrew brings over 35 years of global transaction experience and deep relationships with private equity and family offices, further strengthening GCG’s strategic expansio...
-

Onego Bio startet die Reihe „The Power of Trichoderma reesei”, um Innovationen, Umfang und praktische Anwendungen zu präsentieren

HELSINKI--(BUSINESS WIRE)--Onego Bio, ein Lebensmittelzutatenhersteller, der mithilfe präziser Fermentation* tierfreies Eiprotein produziert, hat heute die Einführung einer neuen Expertenreihe mit dem Titel „The Power of Trichoderma reesei: Building the Future with Fungi.“ Diese mehrteilige Initiative verdeutlicht das volle Potenzial von Trichoderma reesei, der mikrobiellen Plattform hinter Bioalbumen® von Onego, indem sie dessen wissenschaftliche Stärken, industrielle Skalierbarkeit und prakti...
-

Onego Bio lance la série « La puissance de Trichoderma reesei » pour promouvoir innovation, évolutivité et applications concrètes

HELSINKI--(BUSINESS WIRE)--Onego Bio, une entreprise spécialisée dans les ingrédients alimentaires et produisant des protéines d'œufs non animales par fermentation de précision*, a annoncé aujourd'hui le lancement d'une nouvelle série de conférences d'experts intitulée « La puissance de Trichoderma reesei : construire l'avenir avec les champignons. » Cette action en plusieurs volets révèle tout le potentiel de Trichoderma reesei, la plateforme microbienne à l’origine de Bioalbumen® d’Onego, en...
-

LegalShield Data: Rising Consumer Stress Casts Debt Cloud Over Holidays

ADA, Okla.--(BUSINESS WIRE)--Americans kicked off the holiday season with record spending — and record requests for legal help with their debts. LegalShield's Consumer Legal Stress Index (CLSI) climbed to 72.5 in November, its ninth consecutive monthly increase (up 9.4% YoY), driven by a sharp spike in calls about billing disputes, debt collection and loan modifications. The Consumer Finance subindex jumped 4.6% in just two months to 113.3, signaling that financial strain has shifted from a loo...
-

Independent Financial Partners (IFP) Welcomes CenterBridge Planning Group From Commonwealth, Adding Over $700 Million in Client Assets

TAMPA, Fla.--(BUSINESS WIRE)--Independent Financial Partners (IFP) adds CenterBridge Planning Group from Commonwealth, a five-advisor team managing over $700M in assets....
-

Tyk Marks 10 Years in Business by Proving British Tech Can Grow Responsibly

ATLANTA--(BUSINESS WIRE)--Tyk, the independent UK software company powering millions of digital transactions worldwide, is marking its tenth anniversary with B Corp certification - a milestone that recognises a decade of growth built on purpose, not hype. Founded in London in 2014 by Martin Buhr, Tyk began as a one-man side project and has grown into a company of 150 people in 30 countries. Its API management platform now underpins the digital infrastructure of banks, retailers and telcos acros...
-

Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma

BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, today announced that it has initiated two parallel Phase 2a clinical trials evaluating ENV-294, a first-in-class oral small molecule, for the treatment of moderate-to-severe Atopic Dermatitis (AD) and Asthma. "The initiation of these Phase 2a trials is a major step in our strategy to unlock the full potentia...
-

IHI Forum Unites Health Care Professionals to Advance Healthy Aging, Equity, and Innovation

ANAHEIM, Calif.--(BUSINESS WIRE)--The 2025 IHI Forum has convened, bringing together health care leaders, clinicians, patient advocates, and QI professionals from around the world....
-

Pacific Defense Launches Advanced Software-Defined Radio for Electronic Warfare and SIGINT Applications

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Pacific Defense today announced the release of the SDR4320VP, its newest high-performance, ultra-wideband Software-Defined Radio (SDR) transceiver designed for demanding Electronic Warfare (EW), Signals Intelligence (SIGINT), radar, and cyber missions. The 3U OpenVPX plug-in card is aligned with SOSA™, CMOSS, and OpenVPX MOSA standards and supports frequencies up to 18 GHz with 1 GHz of instantaneous analog bandwidth, as well as narrower, digitally processed...